Biotest AG
Biotest AG (BIESF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BIESF · as of Jun 8, 2026
Key Statistics
Explore Biotest AG Data
biesf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
biesf competitorsBIESF
BITGF
CKDXF
CMPUY
CMPVF
DWRKFStock Performance
Full HistoryAbout Biotest AG
Biotest AG Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers…
what is biotest ag · biesf stock overview · biotest ag company profile · who is biotest ag ceo · biesf OTC · biotest ag headquarters · biotest ag business segments
About Stock Overview & Key Data
Biotest AG (BIESF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 9, 2014. As of the latest trading session, BIESF stock price is $32.00, with a market capitalization of $1.6B. The stock has returned +4.99% over the past 12 months and +4.99% year-to-date.
In fiscal year 2024, Biotest AG reported revenue of $726.2M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Biotest AG (BIESF) stock price is $32.00. The stock is traded on OTC under the ticker symbol BIESF. The 52-week range is $30.48 – $32.00.